Adipose-Derived Mesenchymal Stem Cell Administration Does Not Improve Corneal Graft Survival Outcome

• Sherezade Fuentes-Julián ,

  ¶‡ These authors contributed equally to this work.

  Affiliation Cell Engineering Laboratory, IdiPAZ, La Paz Hospital Research Institute, Madrid, Spain

  ⨯
• Francisco Arnalich-Montiel ,

  ¶‡ These authors contributed equally to this work.

  Affiliation Ophthalmology Department, Ramon y Cajal Hospital Research Institute, Madrid, Spain

  ⨯
• Laia Jaumandreu,

  Affiliation Ophthalmology Department, Ramon y Cajal Hospital Research Institute, Madrid, Spain

  ⨯
• Marina Leal,

  Affiliation Ophthalmology Department, Ramon y Cajal Hospital Research Institute, Madrid, Spain

  ⨯
• Alfonso Casado,

  Affiliation Ophthalmology Department, Ramon y Cajal Hospital Research Institute, Madrid, Spain

  ⨯
• Ignacio García-Tuñon,

  Affiliation Cell Engineering Laboratory, IdiPAZ, La Paz Hospital Research Institute, Madrid, Spain

  ⨯
• Enrique Hernández-Jiménez,

  Affiliation Tumor Immunology Department and Innate Immunity Group, IdiPAZ, Madrid, Spain

  ⨯
• Eduardo López-Collazo,

  Affiliation Tumor Immunology Department and Innate Immunity Group, IdiPAZ, Madrid, Spain

  ⨯
• Maria P. De Miguel

  * E-mail: mariapdemiguel@gmail.com

  Affiliation Cell Engineering Laboratory, IdiPAZ, La Paz Hospital Research Institute, Madrid, Spain

  ⨯